These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17592011)

  • 21. Clopidogrel versus ticlopidine after intracoronary stent placement.
    Berger PB; Bell MR; Rihal CS; Ting H; Barsness G; Garratt K; Bellot V; Mathew V; Melby S; Hammes L; Grill D; Holmes DR
    J Am Coll Cardiol; 1999 Dec; 34(7):1891-4. PubMed ID: 10588199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of paclitaxel-eluting stents on restenosis].
    Kurşaklioğlu H; Köz C; Iyisoy A; Ide T; Yildirim V; Töre HF; Işik E; Demirtaş E
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):18-23. PubMed ID: 16524795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should not be continued for more than 1 year and preferably indefinitely.
    Colombo A; Gerber RT
    Circ Cardiovasc Interv; 2008 Dec; 1(3):226-32. PubMed ID: 20031682
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.
    Furuta T
    Intern Med; 2009; 48(21):1847-8. PubMed ID: 19881232
    [No Abstract]   [Full Text] [Related]  

  • 27. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regarding comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy: problems with listing patients receiving clopidogrel for re-transplantation.
    Movahed MR
    JACC Cardiovasc Interv; 2009 May; 2(5):474; author reply 474-5. PubMed ID: 19463475
    [No Abstract]   [Full Text] [Related]  

  • 30. Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention.
    Sardella G; Bucciarelli-Ducci C; Mancone M; Colantonio R; Sangiorgi GM; Fedele F
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):625-8. PubMed ID: 17667035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Late thrombosis in paclitaxel-eluting stent after discontinuation of clopidogrel medication - a case report with 2-year follow-up].
    Wozakowska-Kapłon B; Młodnicki M; Gutkowski W
    Kardiol Pol; 2009 Mar; 67(3):299-303; discussion 304. PubMed ID: 19378238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding and minimizing late thrombosis of drug-eluting stents.
    Rabbat MG; Bavry AA; Bhatt DL; Ellis SG
    Cleve Clin J Med; 2007 Feb; 74(2):129-36. PubMed ID: 17333640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation.
    Joyal D; Rudski L
    J Invasive Cardiol; 2007 Sep; 19(9):E265-7. PubMed ID: 17827517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very late thrombosis after implantation of sirolimus eluting stent.
    Karvouni E; Korovesis S; Katritsis DG
    Heart; 2005 Jun; 91(6):e45. PubMed ID: 15894746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A coronary pseudoaneurysm within a restenotic stent treated by implantation of a pericardium-covered stent and drug-eluting balloon.
    Vaghetti M; Palmieri C
    J Invasive Cardiol; 2013 May; 25(5):E93-5. PubMed ID: 23645061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
    Akbulut M; Ozbay Y; Karaca I; Ilkay E; Gundogdu O; Arslan N
    Coron Artery Dis; 2004 Sep; 15(6):347-52. PubMed ID: 15346093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel-eluting coronary stents.
    Ajani AE; Waksman R
    N Engl J Med; 2004 May; 350(20):2099-100; author reply 2099-100. PubMed ID: 15141053
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous double-culprit in-stent thrombosis. Who is the guilty prisoner behind bars: drug-eluting stent, bare-metal stent, or indication for treatment?
    Mezzapelle G; Baglini R; Baldari D
    Cardiovasc Revasc Med; 2006; 7(4):258-63. PubMed ID: 17174877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
    Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.